ABSTRACT
BACKGROUND AND AIM: Burnout Syndrome (BS) is an illness that became more noticeable due to Coronavirus Disease 2019 (COVID-19) pandemic in result of the increased demand of healthcare systems. The objective of this study is to investigate BS in the participating Pediatric Intensive Care Units (PICU). METHOD(S): This is a cross-sectional observational study, in which the same survey was sent in 2020 and 2021 to the same population. It included questions about demographic data and the Maslach Burnout Inventory - Human Services Survey, that comprises three sub scales: Depersonalizaition (DP), Emotional Exhaustion (EE) and Personal Accomplishment (PA). The questionnaire was electronically sent to the healthcare workers caring for children in the PICU of participating hospitals. The units had both patients with COVID-19 and other illnesses. There was an overall response rate of 28% in both years analyzed. The answers were analyzed by interpreting the answers to the MBI-HSS and possible relations to dependent and independent variables. Also, simple and multiple linear regression models were assembled to compare the mean scores between the categories of the independent variables of interest. RESULT(S): In the year 2020 there was a majority of participants with low DP, moderate PA and low EE. In the following year, there was an increase in PA levels, which were now mainly high, and both of the other two sub scales remained the same. CONCLUSION(S): Although the second wave of COVID presented historically, with a higher number of cases in general, the healthcare workers showed some overall improvement regarding their burnout syndrome levels.
ABSTRACT
Background and Aims: To describe the epidemiological characteristics of patients admitted for COVID19 from March 2020 to January 2021 in our hospital under treatment with statins. Methods: Retrospective descriptive study of a cohort of all patients with COVID-19 admitted to the Infectious Diseases Service at Hospital Infanta Elena from March 2020 to January 2021. Those patients with SARS CoV2 infection documented by PCR of the nasopharyngeal exudate and radiological involvement with risk factors and statin treatment were analyzed. Among these factors are: age over 60 years, chronic cardiovascular and respiratory diseases, type 2 Diabetes Mellitus (DM 2), chronic kidney disease and oncohematological diseases. Results: A cohort of 65 patients was analyzed, of which 23.08% were on statin treatment, with a mean age of 74 + 10.48 sd years, of which 66.7% were men and 33.3% were women. Of the patients taking statins, 86% were smokers and 13.13% were non-smokers. Regarding the rest of the cardiovascular factors, 93.3% were hypertensive, 40% type 2 DM, 20% had a history of coronary disease, 33.3% heart failure, 6.7% COPD, 13.3% chronic kidney disease and 6.7% active neoplasia. In the group that did not take statins, there were 5 deaths (12.2%) and had a median of 10 days of admission, compared to 3 deaths (21.4%) and 11 days of admission in the group that took statins. Conclusions: In our healthcare setting, patients undergoing treatment with statins were admitted less, had less mortality, and their most frequent comorbidities were hypertension, DM2, heart failure and coronary disease.